T2DM was an independent risk factor for SDD in logistic regression analysis; no causal relationship seen in MR analyses

Increase seen in proportion of users without type 2 diabetes, with BMI ≥30, or with BMI of 27 to 30 and obesity-linked comorbidity

Findings even true in adults younger than 40 years of age

Association was attenuated but still significant after adjustment for lifestyle, comorbidities, environmental factors, adiposity

Incidence rate of type 1 diabetes significantly increased after COVID-19 infection

Quarterly out-of-pocket costs increased by approximately $23 on average after age 65 years

No significant increase seen with use of GLP-1 RAs versus SGLT2is or DPP4is among older Medicare beneficiaries

Higher adherence tied to lower inflammatory marker levels over time

Metformin displayed lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had highest risk

By Robin Foster HealthDay ReporterFRIDAY, July 12, 2024 (HealthDay News) — A new report finds research is sorely lacking on how chronic illnesses affect women, and it urged government agencies to do more to investigate how these diseases strike women differently.The National Academies of Sciences, Engineering and Medicine analysis, commissioned …